2026 Q1 Portfolio Activity
In 2026 Q1, Soleus Capital Management, L.P. maintained a portfolio of 119 distinct positions. The most significant new addition was PROGYNY INC, now representing 1.42% of the total fund value. They heavily accumulated shares in KRYSTAL BIOTECH INC, increasing the position by 22.5%. Conversely, Soleus Capital Management, L.P. completely exited their position in SPDR SERIES TRUST.
Position History
hover any row below to update
Loading…
Total Positions
119
Quarter
2026 Q1
Top Holding
KRYS (12.1%)
Top 10 Concentration
50.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 119
Soleus Capital Management, L.P. Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 12.06% | 8.56% |
#1
1
Prev: #2
|
8.5 | 212,028 | 22.5% |
P
S
|
1,153,087 | $297,865,434 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 5.94% | 6.65% |
#2
1
Prev: #3
|
3.9 | -523,880 | -29.0% |
P
S
|
1,284,378 | $146,598,905 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 5.42% | 3.45% |
#3
3
Prev: #6
|
5.7 | 890,007 | 28.4% |
P
S
|
4,029,319 | $133,853,977 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PODD
INSULET CORP
|
Healthcare | 4.78% | 1.57% |
#4
12
Prev: #16
|
5.4 | 412,500 | 275.0% |
P
S
|
562,500 | $118,035,000 | 2020 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
NVCR
NOVOCURE LTD
|
Healthcare | 4.63% | 4.07% |
#5
1
Prev: #4
|
4.9 | 1,961,726 | 23.0% |
P
S
|
10,492,391 | $114,367,062 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 4.50% | 1.08% |
#6
18
Prev: #24
|
4.8 | 127,187 | 212.0% |
P
S
|
187,187 | $110,998,147 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 4.31% | 3.95% |
#7
2
Prev: #5
|
2.2 | -32,449 | -8.9% |
P
S
|
330,517 | $106,489,272 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VCEL
VERICEL CORP
|
Healthcare | 3.32% | 1.01% |
#8
21
Prev: #29
|
4.3 | 1,785,079 | 233.6% |
P
S
|
2,549,079 | $82,003,871 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 2.82% | 1.36% |
#9
11
Prev: #20
|
3.6 | 648,500 | 49.0% |
P
S
|
1,970,864 | $69,689,751 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 2.55% | 1.42% |
#10
9
Prev: #19
|
4.0 | 334,000 | 68.7% |
P
S
|
820,243 | $63,076,687 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
GMED
GLOBUS MED INC
|
Healthcare | 2.55% | 2.86% |
#11
2
Prev: #9
|
1.5 | -157,533 | -17.8% |
P
S
|
729,467 | $62,850,877 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
GERN
GERON CORP
|
Healthcare | 2.50% | 1.13% |
#12
11
Prev: #23
|
4.0 | 18,218,659 | 78.2% |
P
S
|
41,508,659 | $61,847,902 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TWST
TWIST BIOSCIENC...
|
Healthcare | 2.36% | 2.18% |
#13
1
Prev: #12
|
0.9 | -635,173 | -34.1% |
P
S
|
1,226,629 | $58,289,410 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.85% | 0.83% |
#14
23
Prev: #37
|
3.7 | 539,915 | 59.3% |
P
S
|
1,449,915 | $45,672,323 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
BBNX
BETA BIONICS IN...
|
Healthcare | 1.77% | 2.85% |
#15
5
Prev: #10
|
3.7 | 1,819,936 | 71.8% |
P
S
|
4,354,501 | $43,632,100 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 1.76% | 1.03% |
#16
11
Prev: #27
|
3.7 | 61,650 | 88.1% |
P
S
|
131,650 | $43,559,036 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 1.63% | 1.74% |
#17
3
Prev: #14
|
0.7 | -520,202 | -23.1% |
P
S
|
1,726,908 | $40,340,571 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
INDV
INDIVIOR PHARMA...
|
Healthcare | 1.57% | 0.13% |
#18
54
Prev: #72
|
3.6 | 1,174,000 | 1174.0% |
P
S
|
1,274,000 | $38,831,520 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
NPCE
NEUROPACE INC
|
Healthcare | 1.56% | 1.54% |
#19
2
Prev: #17
|
2.6 | 228,999 | 8.5% |
P
S
|
2,932,207 | $38,558,522 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
LIVN
LIVANOVA PLC
|
Healthcare | 1.50% | 1.29% |
#20
1
Prev: #21
|
1.1 | 15,000 | 2.6% |
P
S
|
582,500 | $37,023,700 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 1.50% | 1.67% |
#21
6
Prev: #15
|
0.6 | -173,308 | -30.2% |
P
S
|
400,306 | $36,980,268 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 1.49% | 2.89% |
#22
14
Prev: #8
|
0.6 | -669,428 | -50.7% |
P
S
|
650,572 | $36,750,812 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PGNY
PROGYNY INC
|
Healthcare | 1.42% | — |
#23
Prev: #—
|
4.1 | 2,067,000 | — |
NEW
|
2,067,000 | $35,097,660 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 1.20% | 1.02% |
#24
4
Prev: #28
|
3.5 | 276,900 | 92.5% |
P
S
|
576,299 | $29,725,502 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EDAP
EDAP TMS S A
|
Healthcare | 1.10% | 0.89% |
#25
9
Prev: #34
|
1.4 | no change | no change |
P
S
|
7,309,254 | $27,190,425 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
KNSA
KINIKSA PHARMAC...
|
Healthcare | 1.02% | 0.89% |
#26
7
Prev: #33
|
0.9 | -65,647 | -11.2% |
P
S
|
521,353 | $25,103,147 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 0.99% | — |
#27
Prev: #—
|
3.9 | 203,000 | — |
NEW
|
203,000 | $24,418,870 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ORGO
ORGANOGENESIS H...
|
Healthcare | 0.97% | 1.91% |
#28
15
Prev: #13
|
0.9 | 100,000 | 1.0% |
P
S
|
10,085,951 | $23,903,704 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
NTRA
NATERA INC
|
Healthcare | 0.96% | 0.17% |
#29
39
Prev: #68
|
3.4 | 99,000 | 495.0% |
P
S
|
119,000 | $23,798,810 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
AXGN
AXOGEN INC
|
Healthcare | 0.91% | 1.46% |
#30
12
Prev: #18
|
0.4 | -527,685 | -43.7% |
P
S
|
679,170 | $22,500,902 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 0.91% | 1.04% |
#31
5
Prev: #26
|
0.4 | -223,486 | -36.7% |
P
S
|
385,472 | $22,399,778 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ICLR
ICON PLC
|
Healthcare | 0.86% | — |
#32
Prev: #—
|
3.8 | 192,000 | — |
NEW
|
192,000 | $21,246,720 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 0.80% | 0.72% |
#33
6
Prev: #39
|
1.3 | no change | no change |
P
S
|
702,052 | $19,832,969 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CERS
CERUS CORP
|
Healthcare | 0.79% | 0.30% |
#34
21
Prev: #55
|
3.3 | 6,753,700 | 168.8% |
P
S
|
10,753,700 | $19,571,734 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 0.78% | 0.42% |
#35
13
Prev: #48
|
3.3 | 720,000 | 80.0% |
P
S
|
1,620,000 | $19,326,600 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 0.74% | 0.82% |
#36
2
Prev: #38
|
1.3 | no change | no change |
P
S
|
10,875,000 | $18,270,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 0.74% | — |
#37
Prev: #—
|
3.8 | 6,963,141 | — |
NEW
|
6,963,141 | $18,243,429 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 0.73% | — |
#38
Prev: #—
|
3.8 | 2,002,000 | — |
NEW
|
2,002,000 | $17,937,920 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 0.69% | — |
#39
Prev: #—
|
3.8 | 292,000 | — |
NEW
|
292,000 | $16,979,800 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.66% | — |
#40
Prev: #—
|
3.8 | 546,000 | — |
NEW
|
546,000 | $16,221,660 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 0.61% | — |
#41
Prev: #—
|
3.7 | 783,000 | — |
NEW
|
783,000 | $15,010,110 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.59% | 0.85% |
#42
6
Prev: #36
|
0.2 | -281,231 | -23.1% |
P
S
|
938,163 | $14,541,527 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 0.53% | 0.13% |
#43
30
Prev: #73
|
3.2 | 577,000 | 384.7% |
P
S
|
727,000 | $13,071,460 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.48% | 0.41% |
#44
5
Prev: #49
|
2.2 | 25,000 | 9.3% |
P
S
|
293,500 | $11,766,415 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CORT
CORCEPT THERAPE...
|
Healthcare | 0.47% | — |
#45
Prev: #—
|
3.7 | 285,531 | — |
NEW
|
285,531 | $11,509,755 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 0.45% | 0.45% |
#46
1
Prev: #47
|
1.2 | no change | no change |
P
S
|
796,744 | $11,194,253 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VCYT
VERACYTE INC
|
Healthcare | 0.42% | 0.02% |
#47
41
Prev: #88
|
3.2 | 309,912 | 3099.1% |
P
S
|
319,912 | $10,304,366 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IVVD
INVIVYD INC
|
Healthcare | 0.41% | 0.70% |
#48
8
Prev: #40
|
1.2 | no change | no change |
P
S
|
7,708,727 | $10,021,345 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CCCC
C4 THERAPEUTICS...
|
Healthcare | 0.41% | 0.27% |
#49
9
Prev: #58
|
1.2 | no change | no change |
P
S
|
3,803,942 | $10,004,367 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
KIDS
ORTHOPEDIATRICS...
|
Healthcare | 0.40% | 0.34% |
#50
1
Prev: #51
|
2.2 | 90,000 | 17.1% |
P
S
|
615,447 | $9,767,144 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 |
Showing 1-50 of 119 holdings